Protein synthesis machinery in susceptible microorganism

Protein synthesis in susceptible microorganisms refers not to a single molecule or receptor but rather the entire cellular machinery responsible for translating genetic information into proteins. This process is essential for all living cells and involves multiple components—primarily the ribosome, messenger RNA (mRNA), transfer RNA (tRNA), and various initiation, elongation, and termination factors[1][2][3]. In bacteria and other prokaryotes, this process occurs in the cytoplasm where DNA is transcribed into mRNA; then ribosomes translate this mRNA into polypeptide chains that fold into functional proteins[2][3]. Many antibiotics exploit differences between bacterial and eukaryotic protein synthesis machinery by specifically inhibiting bacterial ribosomes—making "protein synthesis" a key therapeutic target for treating infections[2]. However, "protein synthesis in susceptible microorganisms" is not itself a canonical molecular target but rather describes an essential biological pathway/process. The actual drug targets are typically specific components within this pathway—most notably the bacterial ribosome. Because it refers broadly to a process rather than an individual molecule or defined complex ("receptor"), there is something incorrect about using it as a canonical drug target name—it lacks specificity required for structured pharmacological data models. The correct approach would be to specify particular targets such as "Bacterial 30S ribosomal subunit," "Bacterial 50S ribosomal subunit," etc.[1][2][3].

Other names

Bacterial protein synthesisMicrobial translation machineryRibosomal function in bacteria

Inhibition of ribosomal subunits to block translation initiation or elongation; Disruption of tRNA binding or peptide bond formation on the ribosome